FDA Approves First Strattera Generic, Plus Six Other First-Time Approvals

Generic Line
The FDA approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit hyperactivity disorder in pediatric and adult patients, including multiple strengths manufactured by Apotex, Teva, Aurobindo Pharma and Glenmark Pharmaceuticals.

To View This Article:


Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00